Moneycontrol Be a Pro
Get App
you are here: HomeNewsBusiness
Last Updated : Jan 31, 2018 11:23 AM IST | Source: PTI

Suven gets product patents from Aripo and South Korea

The two patents are valid through 2033 and 2034, respectively, the company said in a BSE filing.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Suven Life Sciences has secured a product patent each from African Regional Intellectual Property Organisation (Aripo) and South Korea corresponding to new chemical entities (NCEs) for the treatment of disorders associated with neurodegenerative diseases.

The two patents are valid through 2033 and 2034, respectively, the company said in a BSE filing.

"We are pleased by the grant of these patents to Suven for our pipeline of molecules in the central nervous system (CNS) arena, which are being developed for cognitive disorders with high unmet medical need with a huge market potential globally," Suven Life CEO Venkat Jasti said.

Close

According to the company, the granted claims of the patents are being developed as therapeutic agents and are useful in treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer's disease, Parkinson and Schizophrenia.

The stock was trading 1 per cent higher at Rs 226.65 apiece on BSE.

The Great Diwali Discount!
Unlock 75% more savings this festive season. Get Moneycontrol Pro for a year for Rs 289 only.
Coupon code: DIWALI. Offer valid till 10th November, 2019 .
First Published on Jan 31, 2018 10:59 am
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant